A Multinational, Randomized, Open-label, Treat-to-Target Trial Comparing Insulin Degludec and Insulin Glargine in Insulin-Naïve Patients with Type 2 Diabetes Mellitus
Main Authors: | Pan, Changyu, Gross, Jorge L., Yang, Wenying, Lv, Xiaofeng, Sun, Li, Hansen, Charlotte Thim, Xu, Hongfei, Wagner, Robert |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer International Publishing
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875929/ |
Similar Items
-
Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus
by: Kusunoki, Yoshiki, et al.
Published: (2013) -
Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial
by: Rodbard, H W, et al.
Published: (2013) -
Health status and hypoglycaemia with insulin degludec versus insulin glargine: a 2-year trial in insulin-naïve patients with type 2 diabetes
by: Rodbard, H W, et al.
Published: (2014) -
Glargine and degludec: solution behaviour of higher dose synthetic insulins
by: Adams, Gary G., et al.
Published: (2017) -
Improved health status with insulin degludec compared with insulin glargine in people with Type 1 diabetes
by: Home, P D, et al.
Published: (2012)